Submission Details
| 510(k) Number | K251258 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | April 23, 2025 |
| Decision Date | June 20, 2025 |
| Days to Decision | 58 days |
| Submission Type | Traditional |
| Review Panel | Cardiovascular (CV) |
| Summary | Summary PDF |
K251258 is an FDA 510(k) clearance for the MC2? Two-Stage Venous Cannula; MC2X? Three-Stage Venous Cannula, a Catheter, Cannula And Tubing, Vascular, Cardiopulmonary Bypass (Class II — Special Controls, product code DWF), submitted by Medtronic, Inc. (Mounds View, US). The FDA issued a Cleared decision on June 20, 2025, 58 days after receiving the submission on April 23, 2025. This device falls under the Cardiovascular review panel. Regulated under 21 CFR 870.4210.
| 510(k) Number | K251258 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | April 23, 2025 |
| Decision Date | June 20, 2025 |
| Days to Decision | 58 days |
| Submission Type | Traditional |
| Review Panel | Cardiovascular (CV) |
| Summary | Summary PDF |
| Product Code | DWF — Catheter, Cannula And Tubing, Vascular, Cardiopulmonary Bypass |
| Device Class | Class II — Special Controls |
| CFR Regulation | 21 CFR 870.4210 |